2018 - Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases, American Academy of Neurology
2018 - Sedgwick Memorial Medal, American Public Health Association
His primary scientific interests are in Alzheimer's disease, Dementia, Cognition, Gerontology and Disease. His Alzheimer's disease research incorporates elements of Central nervous system disease, Degenerative disease and Episodic memory. The various areas that David A. Bennett examines in his Dementia study include Psychiatry, Pediatrics and Cohort study.
David A. Bennett interconnects Developmental psychology and Neuropathology in the investigation of issues within Cognition. His biological study spans a wide range of topics, including Demography, Activities of daily living, Confidence interval, Proportional hazards model and Risk factor. His work focuses on many connections between Disease and other disciplines, such as Neuroscience, that overlap with his field of interest in Neurodegeneration and Gene.
David A. Bennett spends much of his time researching Dementia, Cognition, Alzheimer's disease, Disease and Cognitive decline. His study in Dementia is interdisciplinary in nature, drawing from both Hippocampal sclerosis, Cohort study, Psychiatry, Proportional hazards model and Neuropathology. David A. Bennett has researched Cognition in several fields, including Developmental psychology and Gerontology.
His Gerontology research includes elements of Activities of daily living and Confidence interval. His Alzheimer's disease study incorporates themes from Genetics, Apolipoprotein E and Genome-wide association study. His Disease study typically links adjacent topics like Neuroscience.
His main research concerns Disease, Dementia, Cognitive decline, Cognition and Internal medicine. His studies in Disease integrate themes in fields like Genetics, Neuroscience and Rating scale. The concepts of his Dementia study are interwoven with issues in Incidence, Gerontology, Cohort study, Demography and Alzheimer's disease.
His study looks at the relationship between Alzheimer's disease and topics such as Hippocampal sclerosis, which overlap with Cerebral amyloid angiopathy. The study incorporates disciplines such as Neuropathology and Semantic memory in addition to Cognitive decline. His Cognition research is multidisciplinary, incorporating perspectives in Health literacy and Clinical psychology.
David A. Bennett mainly investigates Dementia, Cognitive decline, Disease, Cognition and Internal medicine. His research integrates issues of Cohort study, Prefrontal cortex, Proportional hazards model, Brain size and Prospective cohort study in his study of Dementia. The Cognitive decline study combines topics in areas such as Metabolite, Endocrinology, Phenotype, Alzheimer's disease and Semantic memory.
David A. Bennett combines subjects such as Hippocampal sclerosis and Protein kinase B with his study of Alzheimer's disease. His Disease research is multidisciplinary, relying on both Microglia, Genetic association and Rating scale. His Cognition research integrates issues from Neuropathology and Clinical psychology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling;Paul S. Aisen;Laurel A. Beckett;David A. Bennett.
Alzheimers & Dementia (2011)
Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Liesi E. Hebert;Paul A. Scherr;Julia L. Bienias;David A. Bennett.
JAMA Neurology (2003)
Vascular Contributions to Cognitive Impairment and Dementia A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Philip B. Gorelick;Angelo Scuteri;Sandra E. Black;Charles Decarli.
Mild cognitive impairment
Serge Gauthier;Barry Reisberg;Michael Zaudig;Ronald C. Petersen.
The Lancet (2006)
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Jean-Charles Lambert;Jean-Charles Lambert;Jean-Charles Lambert;Carla A Ibrahim-Verbaas;Denise Harold;Adam C Naj.
Nature Genetics (2013)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack;David A. Bennett;Kaj Blennow;Maria C. Carrillo.
Alzheimers & Dementia (2018)
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
Ronald C. Petersen;Ronald G. Thomas;Michael Grundman;David Bennett.
The New England Journal of Medicine (2005)
Common variants at MS4A4/MS4A6E , CD2AP , CD33 and EPHA1 are associated with late-onset Alzheimer's disease
Adam C. Naj;Gyungah Jun;Gary W. Beecham;Li-San Wang.
Nature Genetics (2011)
Participation in Cognitively Stimulating Activities and Risk of Incident Alzheimer Disease
Robert S. Wilson;Carlos F. Mendes de Leon;Lisa L. Barnes;Julie A. Schneider.
MIXED BRAIN PATHOLOGIES ACCOUNT FOR MOST DEMENTIA CASES IN COMMUNITY-DWELLING OLDER PERSONS
Julie A. Schneider;Zoe Arvanitakis;Woojeong Bang;David A. Bennett.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: